Publication: Biomarkers of Electroconvulsive Therapy (ECT) Response in Treatment-resistant Schizophrenia (TRS)
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Kathmandu University
Abstract
ABSTRACT
Electroconvulsive therapy (ECT) is a well-established treatment option for individuals
with treatment-resistant schizophrenia (TRS). However, predicting treatment
response and identifying potential biomarkers to guide electroconvulsive therapy
interventions in treatment-resistant schizophrenia remains a challenge. This review
paper aims to explore the current literature on clinical biomarkers associated with
electroconvulsive therapy in treatment-resistant schizophrenia. We discuss various
potential biomarkers, including clinical, neuroimaging findings, EEG markers, and
genetic markers, that have shown promise in predicting electroconvulsive therapy
response and understanding the underlying mechanism of action. Additionally, we
highlight the limitations and future directions for research in this field.
KEY WORDS
Biomarkers, Electroconvulsive therapy, Treatment-resistant schizophrenia
Description
Sharma P,1 Sharma P2
1Department of Psychiatry
University of California
Riverside, CA 92521
2Post Doc Researcher
Yale University
Keywords
Biomarkers, Electroconvulsive therapy, Treatment-resistant schizophrenia